Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.50 |
| ▸ | SOAT1 | P35610 | 5/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TNKS | O95271 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.46 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | AR | P10275 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4500584 | 0.87 | RAB9A (0.56) | RAB9AGRIN2AGRIN2BSOAT1TSHR | |
| SCHEMBL1704979 | 0.84 | RAB9A (0.74) | RAB9AGRIN2AGRIN2BSOAT1TSHR | |
| Hydrochloric Acid SCHEMBL1704951 | 0.83 | RAB9A (0.73) | RAB9AGRIN2AGRIN2BSOAT1TSHR | |
| SCHEMBL4508692 | 0.80 | RAB9A (0.65) | RAB9AGRIN2AGRIN2BSOAT1TSHR | |
| Trifluoroacetic Acid SCHEMBL6282185 | 0.79 | RAB9A (0.60) | RAB9AGRIN2AGRIN2BSOAT1TSHR | |
| SCHEMBL9514091 | 0.75 | RAB9A (0.74) | RAB9AGRIN2AGRIN2BSOAT1TSHR | |
| SCHEMBL9512664 | 0.75 | RAB9A (0.78) | RAB9AGRIN2AGRIN2BSOAT1TSHR | |
| SCHEMBL13617010 | 0.74 | RAB9A (0.73) | RAB9AGRIN2AGRIN2BSOAT1TSHR | |
| SCHEMBL9513272 | 0.74 | RAB9A (0.76) | RAB9AGRIN2AGRIN2BSOAT1TSHR | |
| SCHEMBL8915135 | 0.72 | RAB9A (0.54) | RAB9AGRIN2AGRIN2BSOAT1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7576203-B2 | Method for producing cyclic diamine derivative | KOWA CO., LTD. (JP) | 2009-08-18 | — | — | US | disclosed |
| US-20080045714-A1 | Method for Producing Cyclic Diamine Derivative | KOWA CO., LTD (JP) | 2008-02-21 | — | — | US | disclosed |
| EP-1767527-A1 | METHOD FOR PRODUCING CYCLIC DIAMINE DERIVATIVE | Kowa Co., Ltd. (JP) | 2007-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045714-A1 | Method for Producing Cyclic Diamine Derivative | SAT1, ACAT2, NAT1 | RAB9A 2669/4885GRIN2A 3863/4885GRIN2B 3260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.